Sharechat Logo

Chatham Rock and Boskalis set to extend partnership

Monday 9th July 2012

Text too small?

Deep sea miner Chatham Rock Phosphate will start work on the next stage of its undersea project after meetings last week with Netherlands-based maritime infrastructure company, Royal Boskalis Westminster.

The two companies have been working together since June 2011, with Boskalis designing a process to exact phosphate nodules from the seabed. Boskalis has confirmed its commitment to CRP and will now focus refining its method for recovering and separating the phosphate nodules, which CRP hopes to mine in deep offshore waters on the Chatham Rise, east of Christchurch.

“We see the fledgling deep-sea mining industry as an interesting growth opportunity that fits perfectly with our position as the leading dredging and marine experts," said Peter Berdowski, chief executive at Boskalis said in a statement.

"The Chatham Rise project allows us to draw on our wealth of expertise to contribute to the successful development of this unique project together with our partner Chatham.” Boskalis's key concerns include capital and operating cost, minimisation of possible environmental effects and the optimisation of operating efficiencies. Shares in CRP were unchanged on 25 cents.

BusinessDesk.co.nz



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

December 27th Morning Report
FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors